MERCAPTOPURINE for B precursor type acute leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 484 adverse event reports in the FDA FAERS database where MERCAPTOPURINE was used for B precursor type acute leukaemia.
Most Reported Side Effects for MERCAPTOPURINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 1,853 | 16.1% | 97 | 1,479 |
| Off label use | 893 | 7.8% | 95 | 290 |
| Pyrexia | 855 | 7.4% | 45 | 759 |
| Drug ineffective | 721 | 6.3% | 75 | 230 |
| Vomiting | 488 | 4.3% | 38 | 373 |
| Neutropenia | 485 | 4.2% | 41 | 335 |
| Nausea | 418 | 3.6% | 14 | 304 |
| Pneumonia | 394 | 3.4% | 160 | 202 |
| Pancytopenia | 392 | 3.4% | 66 | 258 |
| Sepsis | 389 | 3.4% | 96 | 268 |
| Abdominal pain | 367 | 3.2% | 14 | 223 |
| Bacterial infection | 365 | 3.2% | 267 | 61 |
| Anaemia | 357 | 3.1% | 17 | 265 |
| Diarrhoea | 352 | 3.1% | 22 | 222 |
| Febrile bone marrow aplasia | 308 | 2.7% | 8 | 302 |
Other Indications for MERCAPTOPURINE
Acute lymphocytic leukaemia (4,815)
Product used for unknown indication (1,136)
Crohn's disease (705)
Colitis ulcerative (512)
B-cell type acute leukaemia (308)
T-cell type acute leukaemia (251)
Chemotherapy (199)
Precursor t-lymphoblastic lymphoma/leukaemia (186)
Acute promyelocytic leukaemia (175)
Non-hodgkin's lymphoma (143)
Other Drugs Used for B precursor type acute leukaemia
BLINATUMOMAB (1,791)
METHOTREXATE (1,067)
VINCRISTINE (977)
DEXAMETHASONE (662)
CYTARABINE (644)
CYCLOPHOSPHAMIDE (598)
PEGASPARGASE (531)
DOXORUBICIN (331)
DAUNORUBICIN (274)
ASPARAGINASE (214)